Enzalutamide Extends Survival in High-Risk Prostate Cancer

Overall survival data from EMBARK trial support enzalutamide plus leuprolide as standard of care.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/enzalutamide-extends-survival-high-risk-prostate-cancer-2025a1000sk5?src=rss

Author :

Publish date : 2025-10-21 14:48:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Enzalutamide Extends Survival in High-Risk Prostate Cancer

Eight countries added to Foreign Office warning list

Don’t Fear Oseltamivir in Kids Hospitalized With Flu

Related Posts

Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

PA- and Physician-Led Heart Transplant Recovery Comparable

Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

Ianalumab’s Success in Phase III Trials Marks a Turning Point in Sjögren’s Disease

How you know if you’ve got a cold or a flu

ACA Enrollment Is Slightly Ahead of Last Year So Far, Despite Expiring Subsidies

Polatuzumab Vedotin With R-CHP Shows Strong Activity in Older DLBCL Patients

PA- and Physician-Led Heart Transplant Recovery Comparable

Novel Orexin Drug Improves Cognitive Symptoms of Narcolepsy Type 1

Ianalumab’s Success in Phase III Trials Marks a Turning Point in Sjögren’s Disease

How you know if you’ve got a cold or a flu

ACA Enrollment Is Slightly Ahead of Last Year So Far, Despite Expiring Subsidies

I’m an Infectious Diseases Doctor. Our Pipeline of Experts Is in Distress.

New BTK Inhibitor Makes Case for Earlier Use in CLL

Categories

Archives